Home  >  News
News
  WuXi AppTec buys US-based CRO, ResearchPoint Global,   October 21, 2017
  US FDA accepts and grant priority review status for Lynparza sNDA in metastatic breast cancer,   October 21, 2017
  Aethlon Medical enters collaboration with iBio to advance large-scale production of Hemopurifier,   October 18, 2017
  US FDA grants priority review status for Bristol-Myers Squibb’s sBLA for Opdivo to treat patients with resected high-risk advanced melanoma,   October 18, 2017
  US FDA approves Janssen's Stelarato to treat adolescents with moderate to severe plaque psoriasis,   October 18, 2017
  US FDA accepts sBLA for Imfinzi to treat patient with locally advanced unresectable NSCLC,   October 18, 2017
  EMA committee recommends approval of Roche’s Alecensa to treat people with ALK-positive NSCLC,   October 16, 2017
  EMA committee recommends approval of Soleno Therapeutics' DCCR to treat Prader-Willi Syndrome,   October 16, 2017
  Global pharma M&A activity continues to grow unabated,   October 16, 2017
  CPhI Worldwide report highlights unpredictability in CDMO growth,   October 16, 2017
  Lilly's Verzenio gets US FDA priority review status to treat advanced breast cancer,   October 14, 2017
  Pfizer receives US FDA approval of Lyrica CR for management of neuropathic pain,   October 14, 2017
  Janssen seeks US FDA approval for apalutamide to treat men with non-metastatic CRPC,   October 13, 2017
  Eurofins to acquire UK forensics market leader, LGC Forensics,   October 13, 2017
  Merck not to seek regulatory approval for anacetrapib as REVEAL outcomes study fails,   October 13, 2017
  Healthsciences International to acquire 70% stake in 3 dental clinics in Singapore for S$3.2 million,   October 12, 2017
  US FDA grants fast track status to Astellas' gilteritinib to treat relapsed/refractory AML,   October 12, 2017
  Pfizer plans to hive off OTC healthcare product businesses,   October 11, 2017
  China Biologic gets CFDA approval for commercial manufacturing of human fibrinogen,   October 11, 2017
  US FDA accepts for review Amgen's sBLA for Prolia to treat patients with glucocorticoid-induced osteoporosis,   October 11, 2017

 Back
 
IPJPI_150x60en_2017
acssymposium
CPhI-WWW-150x60-stat-v1
PHARMACONNECT_2018
 
 
 
 
Copyright © 2016 Saffron Media Pvt. Ltd |